# Personalis, Inc. (PSNL) stock news and updates

As of August 19, 2026. Source: https://www.clearthesis.ai/updates/PSNL

## Our view on the Personalis, Inc. investment thesis

Full investment thesis: https://www.clearthesis.ai/thesis/PSNL

## Personalis, Inc. earnings

In Q2 2026, reported on August 4, 2026, Personalis, Inc. posted earnings of $-0.30 per share against $-0.26 expected, and revenue of $22.4 million against $16.7 million expected.

The next earnings report is expected on November 3, 2026. Analysts expect $-0.26 per share. Revenue is expected around $21.5 million.

What to watch: We are watching clinical test volume, as it shows how quickly doctors are adopting the company's newest cancer monitoring technology.

## Recent analyst activity on PSNL

- July 21, 2026: BTIG Raised target from $11. Price target: $16.25.
- July 20, 2026: Lake Street Downgraded to Hold, set target. Price target: $16.25.
- July 20, 2026: Needham Downgraded to Hold.
- July 20, 2026: BTIG Kept rating at Buy.

## What's ahead for Personalis, Inc.

- November 3, 2026: Earnings report — The company shows how it did over the last three months. The most important update for the stock.

---

Published by Clearthesis (https://www.clearthesis.ai). Informational only, not investment advice.
Full page: https://www.clearthesis.ai/updates/PSNL
